Skip to main content

SYMBIOTEC · Symbiotec Pharmalab Limited

1,611.30 INR -31.10 (-1.89%) At close · Nov 13
Market Cap
103.54B INR
Shares
64.26M
Volume · Nov 13 271.82K Avg daily vol (51 sessions) 1.98M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Investor day
Close1,611.30 INR Open1,635.00 INR Day1,586.60–1,635.00 INR Available close range1,003.35–1,642.40 INR Avg vol 30d1.1M Last earningsNov 6, 2026 DataSep 2026–Nov 2026

The closing range uses available history since Sep 1, 2026; less than a full year is stored.

Latest documents

2026
Sep 22
Earnings call
Q1 2027 earnings call

Symbiotec Pharmalab Limited reported Q1 FY27 revenue of INR218 crores, up 7% year-on-year, EBITDA of INR45 crores and net profit of about INR14 crores. FY27 targets 20% revenue and 25% EBITDA growth; new-business revenues expected in 6 to 12 months.

All documents

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its available closing range
Range low 1,003.35 INR Now 1,611.30 INR · 95% Range high 1,642.40 INR
vs 50-day avg +34%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

5D 20D 120D MTD YTD
XNSE:SYMBIOTEC +6.5% +28.4% — +29.3% —

Exchange listing

Market
XNSE
Ticker
SYMBIOTEC
ISIN
INE899I01028
Security
Ordinary share
Trading currency
INR

Other listings of this company

Share classes and depositary receipts can have different prices and dividends.

Recent dividends

No verified dividend payments are available for this listing yet.

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

  • Earnings call · Q2 2027 2026-11-06 Transcript
    Earnings Call for the Quarter Ended September 30, 2026
  • Earnings call · Q1 2027 2026-09-22 Transcript
    Earnings Call